Tenon Medical Statistics
Total Valuation
Tenon Medical has a market cap or net worth of $7.03 million. The enterprise value is $2.24 million.
Important Dates
The last earnings date was Wednesday, November 13, 2024, after market close.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Tenon Medical has 3.14 million shares outstanding. The number of shares has increased by 176.37% in one year.
| Current Share Class | 3.14M |
| Shares Outstanding | 3.14M |
| Shares Change (YoY) | +176.37% |
| Shares Change (QoQ) | +87.14% |
| Owned by Insiders (%) | 0.68% |
| Owned by Institutions (%) | 2.77% |
| Float | 3.11M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.35 |
| Forward PS | 1.06 |
| PB Ratio | 1.61 |
| P/TBV Ratio | 1.54 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.67 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.52, with a Debt / Equity ratio of 0.06.
| Current Ratio | 3.52 |
| Quick Ratio | 3.16 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -269.29 |
Financial Efficiency
Return on equity (ROE) is -256.26% and return on invested capital (ROIC) is -143.71%.
| Return on Equity (ROE) | -256.26% |
| Return on Assets (ROA) | -84.33% |
| Return on Capital (ROIC) | -143.71% |
| Revenue Per Employee | $157,857 |
| Profits Per Employee | -$653,333 |
| Employee Count | 21 |
| Asset Turnover | 0.33 |
| Inventory Turnover | 2.59 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -86.97% in the last 52 weeks. The beta is 1.92, so Tenon Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.92 |
| 52-Week Price Change | -86.97% |
| 50-Day Moving Average | 3.47 |
| 200-Day Moving Average | 5.47 |
| Relative Strength Index (RSI) | 29.03 |
| Average Volume (20 Days) | 177,042 |
Short Selling Information
The latest short interest is 135,409, so 4.32% of the outstanding shares have been sold short.
| Short Interest | 135,409 |
| Short Previous Month | 206,664 |
| Short % of Shares Out | 4.32% |
| Short % of Float | 4.35% |
| Short Ratio (days to cover) | 0.11 |
Income Statement
In the last 12 months, Tenon Medical had revenue of $3.32 million and -$13.72 million in losses. Loss per share was -$27.13.
| Revenue | 3.32M |
| Gross Profit | 1.92M |
| Operating Income | -13.73M |
| Pretax Income | -14.33M |
| Net Income | -13.72M |
| EBITDA | -13.35M |
| EBIT | -13.73M |
| Loss Per Share | -$27.13 |
Full Income StatementBalance Sheet
The company has $9.16 million in cash and $495,000 in debt, giving a net cash position of $8.67 million or $2.76 per share.
| Cash & Cash Equivalents | 9.16M |
| Total Debt | 495,000 |
| Net Cash | 8.67M |
| Net Cash Per Share | $2.76 |
| Equity (Book Value) | 8.19M |
| Book Value Per Share | 1.42 |
| Working Capital | 8.01M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$9.38 million and capital expenditures -$315,000, giving a free cash flow of -$9.69 million.
| Operating Cash Flow | -9.38M |
| Capital Expenditures | -315,000 |
| Free Cash Flow | -9.69M |
| FCF Per Share | -$3.09 |
Full Cash Flow StatementMargins
| Gross Margin | 57.83% |
| Operating Margin | -414.30% |
| Pretax Margin | -413.88% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | -352.86% |
Dividends & Yields
Tenon Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -176.37% |
| Shareholder Yield | -176.37% |
| Earnings Yield | -200.65% |
| FCF Yield | -141.77% |
Analyst Forecast
The average price target for Tenon Medical is $16.00, which is 614.03% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $16.00 |
| Price Target Difference | 614.03% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on September 6, 2024. It was a reverse split with a ratio of 0.125:1.
| Last Split Date | Sep 6, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.125:1 |
Scores
Tenon Medical has an Altman Z-Score of -9.15 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -9.15 |
| Piotroski F-Score | 4 |